It has been recently suggested that systemic inflammation-based scores such as GPS (including albumin and CRP values), NLR, and PLR might be significant predictors of OS and PFS of cancer patients (de Vivar Chevez et al. 2014 ; Feng et al. 2014 ; Raungkaewmanee et al. 2012 ; Hu et al. 2015 ; Song et al. 2016 ; Nakano et al. 2014 ; Templeton et al. 2014a , b ; Keskin et al. 2014 ).
← all excerpts
Prognostic significance of platelet-lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer.
1
—
—